Leukotriene synthesis inhibitor decreases vasopressin release in the early phase of sepsis (2011)
- Authors:
- USP affiliated authors: SORGI, CARLOS ARTERIO - FCFRP ; FACCIOLI, LUCIA HELENA - FCFRP ; ROCHA, MARIA JOSE ALVES DA - FORP
- Unidades: FCFRP; FORP
- DOI: 10.1016/j.jneuroim.2011.08.001
- Subjects: LEUCOTRIENOS; VASOPRESSINAS; SEPSE
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Neuroimmunology
- ISSN: 0165-5728
- Volume/Número/Paginação/Ano: v. 238, n. 1-2, p. 52-57, 2011
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MARTINS, Thalita Freitas et al. Leukotriene synthesis inhibitor decreases vasopressin release in the early phase of sepsis. Journal of Neuroimmunology, v. 238, n. 1-2, p. 52-57, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.jneuroim.2011.08.001. Acesso em: 15 fev. 2026. -
APA
Martins, T. F., Sorgi, C. A., Faccioli, L. H., & Rocha, M. J. A. da. (2011). Leukotriene synthesis inhibitor decreases vasopressin release in the early phase of sepsis. Journal of Neuroimmunology, 238( 1-2), 52-57. doi:10.1016/j.jneuroim.2011.08.001 -
NLM
Martins TF, Sorgi CA, Faccioli LH, Rocha MJA da. Leukotriene synthesis inhibitor decreases vasopressin release in the early phase of sepsis [Internet]. Journal of Neuroimmunology. 2011 ; 238( 1-2): 52-57.[citado 2026 fev. 15 ] Available from: https://doi.org/10.1016/j.jneuroim.2011.08.001 -
Vancouver
Martins TF, Sorgi CA, Faccioli LH, Rocha MJA da. Leukotriene synthesis inhibitor decreases vasopressin release in the early phase of sepsis [Internet]. Journal of Neuroimmunology. 2011 ; 238( 1-2): 52-57.[citado 2026 fev. 15 ] Available from: https://doi.org/10.1016/j.jneuroim.2011.08.001 - MK-886 did not modify cytokines production but modify vasopressin secretion in the early phase of sepsis
- Blocking peripheral leukotrienes does not decrease the peripheral nitric oxide production and does not affect hydroelectrolity balance and survival rate during experimental sepsis
- Migration of the eosinophil and mononuclear cell numbers to bronchoalveolar fluid peritoneal cavity inteleukin-12 knockout and C57BL/9 mice infected by Strongyloides venezuelensis
- Prostaglandins inhibits immune response in histoplamosis
- 5-LO, FLAP, and BLT1 expression in human T cell lymphotropic virus type 1
- The role of 'beta'-2 integrin in alveolar macrophage phagocytic activity in histoplasmosis
- Role of 5-lipoxigenase on lipid body formation induced by Histoplasma capsulatum cell wall 'beta'-glucan and coinfected immunity
- Papel do TLR2 na histoplasmose experimental
- Leukotrienes in the susceptibility and resistence to infection by Histoplasma capsulatum
- A histoplasmose na mira da ciência
Informações sobre o DOI: 10.1016/j.jneuroim.2011.08.001 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
